Back to News
Market Impact: 0.7

Amplifon Slumps Most Ever on Revenue Miss, Guidance Cut

Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesHealthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
Amplifon Slumps Most Ever on Revenue Miss, Guidance Cut

Amplifon SpA shares plunged as much as 27%, marking its largest intraday loss on record, following disappointing second-quarter results and a significant cut to its 2025 revenue guidance. The hearing-aid specialist reported a 1.7% organic revenue drop in Q2, missing analyst expectations for a 3.3% gain, and now projects only approximately 3% revenue growth for 2025 at constant exchange rates, a sharp reduction from its previous mid-to-high single-digit forecast.

Analysis

Amplifon SpA experienced its largest-ever intraday stock decline, plummeting as much as 27%, following a severe negative revision to its financial outlook and a significant performance miss. The market reaction was driven by a dual shock: second-quarter organic revenue contracted by 1.7%, starkly underperforming analyst consensus which had projected a 3.3% gain. This miss points to a substantial and unexpected deterioration in the company's core business momentum. Compounding this, the firm sharply cut its 2025 revenue growth guidance to approximately 3% at constant exchange rates, a major reduction from the previous forecast for mid-to-high single-digit growth. This downgrade suggests that the operational headwinds are not temporary and have fundamentally altered the company's medium-term growth trajectory, prompting a significant re-rating of the stock by investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment